According to Shenzhen Salubris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 0,09854ย โฌ. In 2024 the company made an earnings per share (EPS) of 0,06504ย โฌ an increase over its 2023 EPS that were of 0,06466ย โฌ.